205 related articles for article (PubMed ID: 5047986)
1. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
Wald I; Galewicz A; Górska D
Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
[No Abstract] [Full Text] [Related]
2. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
Wald I; Galewicz A; Górska D
Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660
[No Abstract] [Full Text] [Related]
3. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
Kanai M; Nomoto S; Tsukagoshi H; Shindo M
Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
[No Abstract] [Full Text] [Related]
4. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
[No Abstract] [Full Text] [Related]
5. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
[No Abstract] [Full Text] [Related]
6. [Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration].
Pakszys W; Ligezińska B; Szymański H
Pol Tyg Lek; 1982 Nov; 37(45):1353-7. PubMed ID: 7163091
[No Abstract] [Full Text] [Related]
7. Value of an enzymatic assay for the determination of serum ceruloplasmin.
Macintyre G; Gutfreund KS; Martin WR; Camicioli R; Cox DW
J Lab Clin Med; 2004 Dec; 144(6):294-301. PubMed ID: 15614251
[TBL] [Abstract][Full Text] [Related]
8. [Pathobiochemistry of Wilson's disease].
Biesold D; Lössner J; Bachmann H; Zotter J
Z Med Lab Diagn; 1982 Oct; 23(5):278-84. PubMed ID: 7180077
[No Abstract] [Full Text] [Related]
9. Immunoenzyme determination of total serum ceruloplasmin. Application to Wilson disease.
Saenko EL; Skorobogatko OV; Yaropolov AI
Biochem Int; 1991 Mar; 23(5):819-24. PubMed ID: 1883396
[TBL] [Abstract][Full Text] [Related]
10. [Copper, ceruloplasmin and the pathogenesis of hepatolenticular degeneration].
Chromý K
Cas Lek Cesk; 1965 Oct; 104(43):1173-7. PubMed ID: 5322100
[No Abstract] [Full Text] [Related]
11. [Hepatolenticular degeneration and hepatocerebral syndromes].
Martynov IuS; Malkova EV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(1):53-7. PubMed ID: 4747508
[No Abstract] [Full Text] [Related]
12. [Wilson's disease: an unusual case].
Llagostera Campillo F; Garrido Botella A; Abreu García L; Barrios Peinado C; Gonzalo Molina MA; Pabón Jaén M; Chantar Barrios C; Fernández Corugedo A; Escartín Marín P
Rev Esp Enferm Apar Dig; 1983 Jul; 64(1):43-8. PubMed ID: 6612070
[No Abstract] [Full Text] [Related]
13. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
SCHEINBERG IH; MORELL AG
J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
[No Abstract] [Full Text] [Related]
14. Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease.
Gollan JL; Stocks J; Dormandy TL; Sherlock S
J Clin Pathol; 1977 Jan; 30(1):81-3. PubMed ID: 838874
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between serum values of copper, ceruloplasmin, SMAO, SDAO, in health- subjects, in pregnant women and in some pathological conditions (author's transl)].
Bombardieri G; Rossi L; Bevilacqua E; Fabiani S; Tettamanti P
Quad Sclavo Diagn; 1976 Jun; 12(2):131-47. PubMed ID: 828961
[TBL] [Abstract][Full Text] [Related]
16. [Hepatolenticular degeneration and pregnancy].
Tsuzuki E; Scaff M; Roitman I; Neme B; Canelas HM
Rev Hosp Clin Fac Med Sao Paulo; 1976; 31(1):35-8. PubMed ID: 1257671
[No Abstract] [Full Text] [Related]
17. [Factors affecting the concentration of serum ceruloplasmin in Wilson-Konovalov disease].
Mzhel'skaia TI; Ivanova-Smolenskaia IA; Korobova NV
Vopr Med Khim; 1994; 40(6):48-53. PubMed ID: 7618303
[TBL] [Abstract][Full Text] [Related]
18. [Fatty liver hepatitis].
Seidler D
Dtsch Med Wochenschr; 1997 Jun; 122(24):802-3. PubMed ID: 9229566
[No Abstract] [Full Text] [Related]
19. Ceruloplasmin, a link between copper and iron metabolism.
Frieden E
Ortop Travmatol Protez; 1969 Sep; 30(9):87-91. PubMed ID: 4910296
[No Abstract] [Full Text] [Related]
20. Wilson's disease patients with normal ceruloplasmin levels.
Yüce A; Koçak N; Ozen H; Gürakan F
Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
